All AbMole products are for research use only, cannot be used for human consumption.
AdipoRon is a novel, and orally bioavailable adiponectin receptor agonist with KD of 1.8 and 3.1 μM for AdipoR1 and AdipoR2, respectively.
AdipoRon (50 μM) dose-dependently attenuates the expression of TNF-α and TGF-β1 in the L02 cells. AdipoRon exhibits significant and dosage-dependent growth suppression on macrophages. AdipoRon treatment significantly improves cardiac functional recovery after reperfusion, and inhibits post-MI apoptosis.
AdipoRon (50 mg/kg, i.v.) cuases significant phosphorylation of AMPK in skeletal muscle and liver of wild-type mice but not Adipor1−/− Adipor2−/− double-knockout mice[1]. AdipoRon (0.02, 0.1, and 0.5 mg/kg, i.g.) alleviates D-GalN induced hepatotoxicity in mice, and prevents hepatic architecture distortion against D-GalN challenge.
 |
Source | Am J Physiol Endocrinol Metab (2015). Figure 2. AdipoRon |
| Method | Myocardial ischemia/reperfusion | |
| Cell Lines | APN knockout (APN-/-) mice | |
| Concentrations | 50 mg/kg | |
| Incubation Time | 24 h | |
| Results | Treatment with AdipoRon significantly improved cardiac functional recovery, as evidenced by increased LV ejection fraction |
 |
Source | Am J Physiol Endocrinol Metab (2015). Figure 1. AdipoRon |
| Method | Myocardial ischemia/reperfusion | |
| Cell Lines | APN knockout (APN-/-) mice | |
| Concentrations | 50 mg/kg | |
| Incubation Time | 24 h | |
| Results | Treatment with AdipoRon significantly improved cardiac functional recovery, as evidenced by improved maximal positive and negative dP/dt |
| Cell Experiment | |
|---|---|
| Cell lines | DG granule cells |
| Preparation method | A baseline recording of DG granule cells from WT mouse brain slices was first made followed by bath application of 15 μM AdipoRon, an AdipoR agonist that binds to both AdipoR1 and AdipoR2 with comparable high affinities. In response to depolarizing current injections (300 ms), AdipoRon treatment decreased the excitability of DG granule neurons, causing reduced number of action potentials elicited by current injections (60–90 pA), increased rheobase current and a more negative resting membrane potential without changing other membrane properties including input resistance, action potential threshold, fAHP and action potential waveforms. |
| Concentrations | 15 μM |
| Incubation time | 24 h |
| Animal Experiment | |
|---|---|
| Animal models | Mice |
| Formulation | DMSO |
| Dosages | 50 mg/kg |
| Administration | oral |
| Molecular Weight | 428.52 |
| Formula | C27H28N2O3 |
| CAS Number | 924416-43-3 |
| Solubility (25°C) | DMSO 55 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related Products |
|---|
| Lactate calcium
Lactate calcium is an excellent calcium fortifier that works better than inorganic calcium. Lactate calcium is used as an antacid. |
| Coniferyl ferulate
Coniferyl ferulate is a potent glutathione S-transferase (GST) inhibitor that reverses multidrug resistance and down-regulates p-glycoprotein. Coniferyl ferulate strongly inhibited human placental glutathione S-transferase with IC50 of 0.3 μM. |
| NXY-059
NXY-059 is a free radical-trapping neuroprotectant that has been reported to reduce infarct size and preserve brain function in experimental models of acute ischemic stroke. |
| Tie2 kinase inhibitor
Tie2 kinase inhibitor is a potent, reversible, and ATP-binding site-targeting Tie2 inhibitor with an IC50 of 250 nM. |
| Calcium levofolinate
Calcium levofolinate is a calcium salt of folinic acid that is an adjuvant used in cancer chemotherapy. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
